跳至主要内容
临床试验/NCT03303391
NCT03303391终止不适用

Using Intradialytic Systolic Blood Pressure Slopes to Guide Ultrafiltration in Hemodialysis Patients: A Validation Study and Clinical Trial

University of Texas Southwestern Medical Center2 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2017年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
14
试验地点
2
主要终点
Change in Mean Ambulatory Systolic Blood Pressure

研究概览

简要总结

This study is an open label randomized clinical trial that comparing intradialytic blood pressure slope-based ultrafiltration prescriptions to standard care in the chronic fluid management of maintenance hemodialysis patients. It also includes a cross sectional component evaluating the associations between intradialytic blood pressure slopes ascertained over 2 week periods with measurements of extracellular water/body weight obtained with multifrequency bioimpedance spectroscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age greater than 18 years
  • End Stage Renal Disease on Maintenance Hemodialysis
  • Hypertension defined as systolic blood pressure > 140 mmHg pre-dialysis or >130 mmHg post dialysis

排除标准

  • Hemodialysis Vintage < 1 month
  • Pregnancy
  • Nadir Systolic Blood Pressure < 95 mmHg
  • Pre or Post dialysis systolic blood pressure > 180 mmHg
  • Decrease in systolic blood pressure >60 mmHg from pre to post dialysis
  • Ultrafiltration rate >13 mL/kg/hr
  • Peridialytic Midodrine Use
  • Intradialytic Clonidine use
  • Documented Antihypertensive Medication Non-adherence
  • Bioimpedance will not be peformed on patients with
  • amputated arms or legs
  • cardiac defibrillator or pacemaker
  • presence of metal prostheses

结局指标

主要结局

Change in Mean Ambulatory Systolic Blood Pressure

时间窗: Baseline, 4 months

The change in mean systolic ambulatory blood pressure from study baseline to completion (4 months)

次要结局

  • Change in Extracellular Volume/Body Weight Ratio(Baseline, 4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Peter Van Buren

Assistant Professor

University of Texas Southwestern Medical Center

研究点 (2)

Loading locations...

相似试验